The Latest Headlines at American Banking and Market News
Gregory W. Buckley Acquires 1,070 Shares of Adams Natural Resources Fund, Inc. (NYSE:PEO) Stock
Adams Natural Resources Fund, Inc. (NYSE:PEO – Get Free Report) VP Gregory W. Buckley bought 1,070 shares of the firm’s stock in a transaction on Wednesday, May 1st. The shares were purchased at an average price of $23.06... More of this article »
George R. Sisson III Purchases 1,000 Shares of C&F Financial Co. (NASDAQ:CFFI) Stock
C&F Financial Co. (NASDAQ:CFFI – Get Free Report) Director George R. Sisson III acquired 1,000 shares of the company’s stock in a transaction on Tuesday, April 30th. The shares were bought at an average cost of $39.47... More of this article »
Claire Hatton Buys 2,136 Shares of Lifestyle Communities Limited (ASX:LIC) Stock
Lifestyle Communities Limited (ASX:LIC – Get Free Report) insider Claire Hatton purchased 2,136 shares of the stock in a transaction that occurred on Friday, April 26th. The shares were purchased at an average price of A$11.65... More of this article »
Tracey Horton Purchases 1,500 Shares of IDP Education Limited (ASX:IEL) Stock
IDP Education Limited (ASX:IEL – Get Free Report) insider Tracey Horton purchased 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, April 30th. The shares were purchased at an average price... More of this article »
Henry L. Pujol Sells 9,944 Shares of Royal Caribbean Cruises Ltd. (NYSE:RCL) Stock
Royal Caribbean Cruises Ltd. (NYSE:RCL – Get Free Report) CAO Henry L. Pujol sold 9,944 shares of Royal Caribbean Cruises stock in a transaction on Tuesday, April 30th. The stock was sold at an average price of $141.23, for a... More of this article »
Daniel R. Hart Sells 2,826 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) Stock
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Free Report) CFO Daniel R. Hart sold 2,826 shares of the company’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $7.40, for a total... More of this article »
Rosty Raykov Sells 2,431 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) Stock
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) CEO Rosty Raykov sold 2,431 shares of the business’s stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $9.11, for a total... More of this article »
MiMedx Group’s (MDXG) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of MiMedx Group (NASDAQ:MDXG – Free Report) in a research note released on Wednesday, Benzinga reports. HC Wainwright currently has a $11.00 target price on the stock. HC Wainwright... More of this article »
JPMorgan Chase & Co. Boosts Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30.00
Kiniksa Pharmaceuticals (NASDAQ:KNSA – Free Report) had its target price upped by JPMorgan Chase & Co. from $26.00 to $30.00 in a research note published on Wednesday, Benzinga reports. The brokerage currently has an overweight... More of this article »
Needham & Company LLC Reaffirms Buy Rating for KalVista Pharmaceuticals (NASDAQ:KALV)
Needham & Company LLC reaffirmed their buy rating on shares of KalVista Pharmaceuticals (NASDAQ:KALV – Free Report) in a report published on Wednesday morning, Benzinga reports. The brokerage currently has a $35.00 target... More of this article »
Floyd F. Petersen Sells 500 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) Director Floyd F. Petersen sold 500 shares of the company’s stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $41.67,... More of this article »
Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Bought by International Assets Investment Management LLC
International Assets Investment Management LLC lifted its stake in shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 248,773.8% during the fourth quarter, according to its most recent disclosure with the Securities... More of this article »
Wedbush Reaffirms “Outperform” Rating for Landsea Homes (NASDAQ:LSEA)
Wedbush reaffirmed their outperform rating on shares of Landsea Homes (NASDAQ:LSEA – Free Report) in a research report report published on Wednesday morning, Benzinga reports. The brokerage currently has a $16.00 target price... More of this article »